战略目标[Strategic objectives]

        艾洛特医药研究院是南京市重点建设的高水平新型研发机构，构建了院士领衔的创新团队，形成了特色鲜明的国际创新生物药管线体系，得到了南京市、江宁区和江宁高新区大力支持。协同创新中心实施单位3T成立于2011年位于美国波士顿，在新技术开发、创新项目储备、信息资源获取、海外人才集聚和政策推广方面具备得天独厚优势。在江宁高新区管委会指导下，充分发挥国内外信息资源、人才资源、项目资源综合优势，立足做实做强市海外协同创新中心，确保有效“生根”。战略目标包括：合理规划基础设施建设；系统整合国内外资源对接；务实推动先进生物医药成果引进；稳步落实江宁优势宣传推广；扎实提升运营管理。

        Jiangsu Cell Tech Research Institute Co. Ltd. (hereinafter called " Cell Tech ") is a high-level new research and development institution of Nanjing, which has built an innovative team led by academicians and formed an international innovative biological drug pipeline system with distinctive characteristics. Cell Tech has received strong support from Nanjing, Nanjing Jiangning District and Nanjing Jiangning Hi-tech Zone. Boston 3T Biotechnologies INC. (hereinafter called "3T"), the implementation unit of collaborative innovation center, was founded in Boston in 2011. It has unique advantages in new technology development, innovation project reserve, information resource acquisition, overseas talent gathering and policy promotion. Under the guidance of the Management Committee of Jiangning Hi-tech Zone, we will give full play to the comprehensive advantages of information resources, human resources and project resources at home and abroad, establish and strengthen the city's overseas collaborative innovation center, and ensure its effective operation. The strategic objectives include: rational planning of infrastructure construction, system integration of domestic and foreign resources docking, promoting the introduction of advanced biomedical achievements, steadily implement Jiangning advantage publicity and promotion, solid improvement of operation management.